| Patient | Emile Griffith |
|---|---|
| Date of birth | 1938-02-03 |
| Identifiers | MRN HR-BX005-SYN-TD; SSN (made up) 000-05-6418 |
| Document date | 2005-09-15 |
| Author | Celeste Fairbanks-Ochieng, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review of PTSD, mood and memory. [S]
Emile Griffith returns with his care partner. He finished twelve sessions of cognitive processing therapy five weeks ago. He says he no longer blames himself in the same way: he went into the ring to win, not to hurt anyone, and he can now speak about his opponent without dreading the memory. Nightmares come about once a week. He takes sertraline 50 mg each morning without nausea, dizziness or bleeding. He completed ten sessions of physical therapy two weeks ago and does the home exercises most days; he has had no falls. His care partner notices no change in his memory. No thoughts of suicide. [S]
| Element | Detail |
|---|---|
| PCL-5 | 26, from 41 at intake |
| PHQ-9 | 5; item 9 scored 0 |
| Sodium | 137 mmol/L on sertraline 50 mg |
| Nightmares | About once a week |
| Timed Up and Go | 10 seconds |
| System | Result | Finding |
|---|---|---|
| Psychiatric | Positive | Nightmares about once a week; mood good; no thoughts of suicide |
| Neurological | Positive | Forgetfulness unchanged; no headaches, weakness or tremor |
| Gastrointestinal | Negative | No nausea or diarrhea |
| Musculoskeletal | Negative | No falls; legs feel stronger |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 25 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2005-05-05 to 2005-06-16 | completed | S |
| Sertraline 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2005-06-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2005-09-15 | Body height | 170 | cm | S |
| 2005-09-15 | Body weight | 73.9 | kg | S |
| 2005-09-15 | Body mass index (BMI) [Ratio] | 25.6 | kg/m2 | S |
| 2005-09-15 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2005-09-15 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2005-09-15 | Heart rate | 66 | /min | S |
| 2005-09-15 | Respiratory rate | 14 | /min | S |
| 2005-09-15 | Body temperature | 36.7 | Cel | S |
| 2005-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2005-09-15 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 2005-09-15 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2005-09-15 | PTSD PCL-5 score [PCL-5] | 26 | {score} | S |
Vital signs recorded on 2005-09-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 128/76 mmHg; pulse 66; weight 73.9 kg |
| Musculoskeletal | Timed Up and Go 10 seconds; tandem walk without a side-step |
| Mental status | Bright and relaxed; speaks about the fight calmly; no psychotic symptoms; denies thoughts of suicide |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be found | resolved | confirmed | R41.3 | S — Synthetic presenting problem anchored to the documented short-term memory problems; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41 | active | confirmed | F43.12 | S — Synthetic modern diagnosis at intake by clinical interview against DSM-5-TR criteria, anchored to his public words about lifelong nightmares; not a historical diagnosis. |
| Mild cognitive impairment (mild neurocognitive disorder) with slowed processing, executive and memory-retrieval deficits, most likely due to traumatic brain injury from a nineteen-year professional boxing career and a severe assault; meets the NINDS research criteria for traumatic encephalopathy syndrome (a research diagnosis); Alzheimer's disease co-pathology not excluded | active | confirmed | G31.84 | S — Synthetic modern diagnosis at the third visit after MRI and neuropsychological testing; anchored to the documented memory problems and pugilistic dementia, not a retrospective diagnosis of his real illness. |
| Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospital | active | confirmed | Z87.820 | S — Synthetic coding of the documented career and assault. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Cognitive testing (MoCA) | At diagnosis, then yearly, or sooner with change | Up to date | MoCA 22 at intake; no change reported; next at the yearly review |
| Survey | Staging (CDR) and function (ADL and IADL) | At diagnosis, then yearly | Up to date | CDR 0.5 at two weeks; function unchanged |
| Examination | Medicine review for anticholinergic, sedating and fall-risk drugs (Beers) | Every visit | Completed today | Sertraline 50 mg only |
| Survey | Neuropsychiatric symptom screen (apathy, irritability, paranoia, impulsivity) | Every visit | Completed today | No apathy, irritability, paranoia or impulsive behavior |
| Survey | PHQ-9 with suicide-risk review (item 9 and structured questions) | Monthly during acute treatment; every visit during active treatment | Completed today | PHQ-9 5, item 9 scored 0; no thoughts of suicide |
| Survey | PCL-5 | Baseline, then at each chronic-care visit during treatment; response judged after 8 to 12 weeks | Completed today | PCL-5 26: a clinically meaningful 15-point fall |
| Medication safety | Sertraline: nausea, sleep, falls, bleeding, and sodium (SSRIs can lower sodium in older adults) | Two weeks after starting and after each dose change; sodium at those points | Deferred | Deviation: the sodium check ordered for two to four weeks after the increase to 50 mg was not done, because no visit fell then and the lab-only appointment was never scheduled. It was done today, three months after the increase: 137 mmol/L, normal, with no confusion, falls or other sign of low sodium, so no harm is known. Corrective action: a lab-only appointment is now booked automatically with any antidepressant start or dose change |
| Referral | Trauma-focused psychotherapy (cognitive processing therapy) | Weekly, about twelve sessions | Completed today | Twelve sessions completed five weeks ago |
| Examination | Fall risk (Timed Up and Go, gait and balance), STEADI | At diagnosis, yearly, and after any fall | Completed today | Timed Up and Go 10 seconds; no falls |
| Referral | Physical therapy for balance and strength | Once, after a Timed Up and Go above 12 seconds | Completed today | Ten sessions completed two weeks ago; home program continues |
| Self-management | Travel, money and home safety | At diagnosis and each follow-up | Completed today | No episodes of getting lost; shared oversight of bills working |
| Survey | Care partner support and burden (Zarit Burden Interview, narrative) | At diagnosis, then every 6 to 12 months | Up to date | Zarit 14 at the diagnosis visit; his care partner attends the caregiver class; next check at about six months |
| Self-management | Advance care planning | At diagnosis; revisit yearly and at changes | Completed today | Health care agent named and goals recorded at the annual wellness visit six weeks ago; reviewed today without change |
| Examination | Vascular risk factors (blood pressure, weight) | Every visit | Completed today | Blood pressure 128/76 mmHg; weight 73.9 kg |
Goal progress:
Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024)
Follow-up: Six-month review in six weeks with PCL-5 and PHQ-9, influenza vaccine and the second zoster dose. Call the clinic or 988 at any time if thoughts of suicide arise. Next scheduled visit 2005-10-27: six-month review: PTSD, mood, cognition, safety and the plan for the year ahead. [S]